Expired contract
Supportive Medicine - Propofol 1g/50ml (emulsion for infusion vials) for ITU
Details
- Supplier(s)
- FRESENIUS KABI LIMITED
- Value
- GBP 59,600
- Duration
- 1 year
- Topic
- Pharmaceutical products
- Published
- 17 June 2022
- Source
- uk:contracts_finder
Tender description
Award for the supply of Supportive Medicine - Propofol 1g/50ml (emulsion for infusion vials) for ITU.
Timeline
- Completed: Award date14 June 2022
- Completed: Award published17 June 2022Current notice
- Completed: Contract expiry date13 June 2023
About the buyer
UK Health Security Agency is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@uk-health-security-agency.gov |
6 similar open tenders
See more open tenders related to Supportive Medicine - Propofol 1g/50ml (emulsion for infusion vials) for ITU.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to UK Health Security Agency.
BuyersCountValue
- 2,594£1.6bn
- 880£19.4bn
- 677£8.8bn
- 423£3.8bn
- 339£20.2m
- 290£366.8m
- 256£233.2m
- 246£577.4m
- 232£10.1bn
- 168£47.4m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
